Welcome to "The Poster!" To become a subscriber and start getting updates on new content, subscribe now!
In the News
Community | The Intellectual Property and Strategic Agreements Office Moves FNL Technologies Forward
Science & Technology | Anticancer Antibody Receives First Funds for Trial in Leukemia Patients
An anti-leukemia compound identified at NCI at Frederick is one step closer to entering clinical trials in humans thanks to a $4.2-million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). CPRIT recently gave the funds to Allterum Therapeutics, Inc., a Texas-based biotechnology startup company created to manufacture the compound, Allterum, and advance it to human trials. The grant represents the first step in the multi-million-dollar process to bring Allterum to the clinic.
O&M News | Operations and Maintenance March Newsletter
There are many safety rules and regulations designed to keep us safe as we carry out our individual tasks at NCI, but this issue of the O&M Newsletter is all about evacuation. Specifically, it highlights the importance of the systems and components that ensure the safe evacuation of all building occupants in emergency situations.